SALIVARY ELIMINATION OF PYRIMETHAMINE

被引：9

作者：

AHMAD, RA

ROGERS, HJ

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1981年 / 11卷 / 01期

关键词：

D O I：

10.1111/j.1365-2125.1981.tb01114.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：101 / 102

页数：2

共 9 条

[1] PHARMACOKINETICS AND PROTEIN-BINDING INTERACTIONS OF DAPSONE AND PYRIMETHAMINE [J].

AHMAD, RA ;

ROGERS, HJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (05) :519-524

[2]

CAVALLITO JC, 1978, DRUG METAB DISPOS, V6, P329

[3]

COHN VH, 1971, FUNDAMENTALS DRUG ME, P18

[4] THERAPEUTIC DRUG MONITORING IN SALIVA [J].

DANHOF, M ;

BREIMER, DD .

CLINICAL PHARMACOKINETICS, 1978, 3 (01) :39-57

[5]

GALEAZZI RL, 1976, CLIN PHARMACOL THER, V20, P278

[6] TREATMENT OF MENINGEAL LEUKEMIA WITH PYRIMETHAMINE [J].

GEILS, GF ;

SCOTT, GW ;

BAUGH, CM ;

BUTTERWORTH, CE .

BLOOD-THE JOURNAL OF HEMATOLOGY, 1971, 38 (02) :131-+

[7] DETERMINATION OF PLASMA-CONCENTRATIONS OF DAPSONE, MONOACETYL DAPSONE AND PYRIMETHAMINE IN HUMAN-SUBJECTS DOSED WITH MALOPRIM [J].

JONES, CR ;

OVENELL, SM .

JOURNAL OF CHROMATOGRAPHY, 1979, 163 (02) :179-185

[8]

MATIN SB, 1974, CLIN PHARMACOL THER, V16, P1052

[9] PERSISTENT EXCRETION OF PYRIMETHAMINE FOLLOWING ORAL ADMINISTRATION [J].

SMITH, CC ;

IHRIG, J .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1959, 8 (01) :60-62

← 1 →